Biofrontera AG Stock News

Biofrontera (NASDAQ: BFRI ) stock is on the move Friday alongside heavy trading of the biopharmaceutical company's shares. This has more than 4.3 million shares of BFRI stock changing hands as of thi

Biofrontera (NASDAQ: BFRI ) reported results for the first quarter of 2023. Biofrontera posted a loss per share of 28 cents.

Biofrontera AG (OTC:BFAGY) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Anke zur Mühlen - Corporate Communications & Investor Relations Ludwig Lutter - Chief Financia

Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany

Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript

Biofrontera Stock Plunges After Announcing Nasdaq Delisting

Biofrontera <> announced that the company decided to delist its American Depositary Shares ((ADS)) from the Nasdaq Capital Market

Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy back the shares they initially borrowed at a higher price. A squeeze can occur when short sellers are forced into buying to cover their position, which can cause shares to go much higher on many occasions. Fintel Data: Data from Fintel , which requires a subscription, provides a look at several of the top shorted stocks and data on how likely a short squeeze is to occur. Heres a look at Fintels top five short squeeze candidates for the week of Feb. 7. Vinco Ventures: Topping the list this week is Full story available on Benzinga.com

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Biofrontera Inc (NASDAQ: BFRI ) has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-RhodoLED lamp in the U.S. To date, 70% of the planned 186 patients have been enrolled in the study. Patient recruitment for this study has been ongoing since 2018, with the Full story available on Benzinga.com

Biofrontera <> is trading sharply higher after announcing that the company enrolled 70% of patients in its Phase 3 study for Ameluz photodynamic therapy in superficial basal…

Biofrontera (BFRI) +14%. Synaptogenix (SNPX) +11%. Sio Gene Therapies (SIOX) -19%. Anavex Life Sciences (AVXL) -16%.

Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-Rhod

Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indic